Sticky inflation and strong jobs tilt the Fed toward hikes, compressing long-duration tech valuations.
Planet is compounding 42% growth with $700M cash and raising more dry powder while space is hot
AI productivity gains accrue first to concentrated US mega-cap tech, lifting the Nasdaq-100 above global peers.
Lilly's $1T value rests on tirzepatide, but the patent cliff caps it far short of a $100T dream
Revolution Medicines drugged the undruggable RAS, doubling pancreatic cancer survival vs chemo
Tango's drug stacks on the new pancreatic standard and pushes survival even further
EO-fast-tracked microreactors are going critical, and every one needs TRISO fuel BWXT fabricates.